The PROLONG Trial - Rituximab Maintenance Therapy in ITP

PHASE3Active, not recruitingINTERVENTIONAL
Enrollment

136

Participants

Timeline

Start Date

December 31, 2016

Primary Completion Date

December 31, 2024

Study Completion Date

December 31, 2024

Conditions
Purpura, Thrombocytopenic, Idiopathic
Interventions
DRUG

Dexamethasone

Comparing the effect of Rituximab infusion With or without Dexamethasone

DRUG

Rituximab

Comparing maintenance dose of 500mg Rituximab at week 1 and week 24 to Placebo

Trial Locations (1)

1714

Ostfold Hospital Trust, Sarpsborg

All Listed Sponsors
collaborator

Oslo University Hospital

OTHER

collaborator

St. Olavs Hospital

OTHER

collaborator

Helse Stavanger HF

OTHER_GOV

collaborator

University Hospital of North Norway

OTHER

collaborator

Haukeland University Hospital

OTHER

collaborator

Odense University Hospital

OTHER

collaborator

Centre Hôpital Universitaire Farhat Hached

OTHER

collaborator

Henri Mondor University Hospital

OTHER

collaborator

University Hospital, Akershus

OTHER

collaborator

Cairo University

OTHER

lead

Ostfold Hospital Trust

OTHER